Dr. Logothetis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Barnes-Jewish Hospital
One Barnes-Jewish Plaza
Saint Louis, MO 63110
Education & Training
- University of South Florida MorsaniResidency, Internal Medicine, 2019 - 2022
- University of New Mexico School of MedicineClass of 2019
Certifications & Licensure
- MO State Medical License 2022 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study.Damian A Laber, Parth C Patel, Constantine N Logothetis, Ankita K Patel, Michael Jaglal
European Journal of Haematology. 2024-03-01 - Bendamustine and rituximab as frontline therapy in extranodal marginal zone lymphoma: a single-institution experience.Constantine N Logothetis, Nathan P Horvat, Tony Kurian, Celeste Bello, Julio Chavez
Oncology Research. 2024-01-01 - A Retrospective Analysis of Vitamin D Levels in Hospitalized COVID-19 Patients With Suspected Pulmonary Embolism.Shaun V Charkowick, Constantine N Logothetis, Katherine Tsay, Aryanna Jordan, Catherine Hanna
Cureus. 2023-07-01
Journal Articles
- Exosomal Secretion of a Psychosis-altered miRNA that Regulates Glutamate Receptor Expression is Affected by AntipsychoticsAmoah S.K., Rodriguez B.A, Logothetis C.N., Chander P., Sellgren C.M., Weick J.P., Sheridan S.D., Jantzie L.L., Webster M.J., Mellios N., Neuropsychopharmacology, 11/27/2019
Abstracts/Posters
- Incidence and Management of Venous Thrombo-Embolism (VTE) Associated with CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Single Institution ExperienceHashmi H., Mirza A.S., Darwin A., Logothetis C.N., Garcia F., Kommalapati A., Bachmeier C.A., Chavez J.C., Shah B.D., Pinilla-Ibarz J., Khimani F., Lazaryan A., Liu H...., Biology of Blood and Marrow Transplantation, 3/1/2020
- Hypofibrinogenemia in Patients Receiving CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Large B Cell Lymphoma: A Single Institution ExperienceHashmi H., Mirza A.S., Darwin A., Logothetis C.N., Garcia F., Kommalapati A., Bachmeier C.A., Chavez J.C., Shah B.D., Pinilla-Ibarz J., Khimani F., Lazaryan A., Liu H...., Biology of Blood and Marrow Transplantation, 3/1/2020
- Incidence and Management of Effusions during CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Receptor Therapy in B-Cell Lymphoma: A Single Institution ExperienceMirza A.S., Hashmi H., Darwin A., Garcia F., Kommalapati A., Logothetis C.N., Bachmeier C.A., Chavez J.C., Shah B.D., Pinilla-Ibarz J., Khimani F., Lazaryan A., Liu H...., Biology of Blood and Marrow Transplantation, 3/1/2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: